2193-PUB: Effect of One Month Basal Insulinization in Addition to OADs Initiation on Glycemic Parameters in Newly Diagnosed Treatment-Naïve Type 2 Diabetes Patients Presenting with Osmotic Symptoms or Glucotoxicity: A Long-Term Follow-Up Study

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 2193-PUB
Author(s):  
BALAJI JAGANMOHAN ◽  
PRAVEER R. MATHUR ◽  
SAMBIT DAS ◽  
MANIKANDAN RM ◽  
P SANJOY ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Newly Diagnosed ◽  
Follow Up Study ◽  
Long Term Follow Up ◽  
Treatment Naïve ◽  
Diabetes Patients

scholarly journals Sex Difference in Effects of Low-Dose Aspirin on Prevention of Dementia in Patients With Type 2 Diabetes: A Long-term Follow-up Study of a Randomized Clinical Trial

Diabetes Care ◽  
2019 ◽  
Vol 43 (2) ◽  
pp. 314-320 ◽  
Author(s):  
Chisa Matsumoto ◽  
Hisao Ogawa ◽  
Yoshihiko Saito ◽  
Sadanori Okada ◽  
Hirofumi Soejima ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Low Dose ◽  
Follow Up Study ◽  
Dose Aspirin ◽  
Low Dose Aspirin ◽  
Long Term Follow Up

Effectiveness of family involvement in newly diagnosed type 2 diabetes patients: a follow-up study

2016 ◽  
Vol 99 (5) ◽  
pp. 776-782 ◽  
Author(s):  
Mai Shi ◽  
Mei-Yan Xu ◽  
Zhao-Lan Liu ◽  
Xue-Ying Duan ◽  
Yan-Bo Zhu ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Family Involvement ◽  
Newly Diagnosed ◽  
Follow Up Study ◽  
Diabetes Patients

Biliopancreatic diversion, type 2 diabetes mellitus and metabolic syndrome: Long-term follow-up study

2005 ◽  
Vol 1 (3) ◽  
pp. 273
Author(s):  
Gian Franco Adami ◽  
Francesco Papadia ◽  
Giuseppe Marinari ◽  
Giovanni Camerini ◽  
Nicola Scopinaro
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Metabolic Syndrome ◽  
Type 2 Diabetes Mellitus ◽  
Biliopancreatic Diversion ◽  
Follow Up Study ◽  
Long Term Follow Up

scholarly journals Occurrence of comorbidities in newly diagnosed type 2 diabetes patients and their impact after 11 years’ follow-up

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Sophia Eilat-Tsanani ◽  
Avital Margalit ◽  
Liran Nevet Golan
Keyword(s):  
Type 2 Diabetes ◽  
Diabetes Management ◽  
Newly Diagnosed ◽  
Risk Of Death ◽  
High Prevalence ◽  
Long Term Follow Up ◽  
New Onset

AbstractThe burden of type 2 diabetes is growing, not only through increased incidence, but also through its comorbidities. Concordant comorbidities for type 2 diabetes, such as cardiovascular diseases, are considered expected outcomes of the disease or disease complications, while discordant comorbidities are not considered to be directly related to type 2 diabetes and are less extensively addressed under diabetes management. Here we show that the combination of concordant and discordant comorbidities appears frequently in persons with diabetes (75%). Persons with combined comorbidities visited family physicians more than persons with discordant, concordant or no comorbidity (17.3 ± 10.2, 11.6 ± 6.5, 8.7 ± 6.8, 6.3 ± 6.6 visits/person/year respectively, p < 0.0001). The risk of death during the study period was highest in persons with combined comorbidities and discordant only comorbidities (HR = 33.4; 95% CI 12.5–89.2 and HR = 33.5; 95% CI 11.7–95.8), emphasizing the contribution of discordant comorbidities to the outcome. Our study is unique as a long-term follow-up of an 11-year cohort of 9725 persons with new-onset type 2 diabetes. The findings highlight the contribution of discordant comorbidity to the burden of the disease. The high prevalence of the combination of both concordant and discordant comorbidities, and their appearance before the onset of type 2 diabetes, indicates a continuum of morbidity.

scholarly journals Increment of C-peptide after glucagon injection determines the progressive nature of Japanese type 2 diabetes: A long-term follow-up study

2013 ◽  
Vol 60 (6) ◽  
pp. 715-724 ◽  
Author(s):  
Tomoyasu Fukui ◽  
Kayoko Oono ◽  
Noriko Hara ◽  
Takeshi Yamamoto ◽  
Masaharu Nagashima ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
C Peptide ◽  
Follow Up Study ◽  
Long Term Follow Up ◽  
Glucagon Injection

564-P: Long-Term Follow-up of Glycemic Excursion Minimization (GEM) Compared with Weight Loss in Management of Type 2 Diabetes (T2D)

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 564-P
Author(s):  
DANIEL COX ◽  
MATTHEW A. MONCRIEF ◽  
ANTHONY L. MCCALL
Keyword(s):  
Type 2 Diabetes ◽  
Weight Loss ◽  
Long Term Follow Up
Sign in / Sign up

Export Citation Format

Share Document